Raymond James Financial Services Advisors’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$179K Sell
2024
Q2
$157K Buy
2024
Q1
$149K Sell
2023
Q4
$169K Sell
2023
Q3
$126K Sell
2023
Q2
$134K Hold
2023
Q1
$145K Buy
2022
Q4
$103K Hold
2022
Q3
$141K Hold
2022
Q2
$100K Buy
2022
Q1
$110K Sell
2021
Q4
$191K Buy
2021
Q3
$202K Sell
2021
Q2
$281K Sell
2021
Q1
$205K Buy